UPDATE 1-U.S. FDA panel backs Novartis' pioneering new cancer gene therapy
July 12, 2017 at 16:48 PM EDT
July 12 (Reuters) - Novartis AG's pioneering new cancer drug won enthusiastic support from a federal advisory panel on Wednesday, paving the way for approval of the first U.S. gene therapy.
